These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30552020)

  • 1. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate lymphoid cells link gut microbes with mucosal T cell immunity.
    Castellanos JG; Longman RS
    Gut Microbes; 2020; 11(2):231-236. PubMed ID: 31347946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
    Longman RS; Diehl GE; Victorio DA; Huh JR; Galan C; Miraldi ER; Swaminath A; Bonneau R; Scherl EJ; Littman DR
    J Exp Med; 2014 Jul; 211(8):1571-83. PubMed ID: 25024136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
    Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
    Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression.
    Zhao C; Wang D; Wu M; Luo Y; Yang M; Guo J; Zhang H; Zhang X
    J Int Med Res; 2020 Jun; 48(6):300060520926011. PubMed ID: 32567429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells.
    Ferdinand JR; Richard AC; Meylan F; Al-Shamkhani A; Siegel RM
    J Immunol; 2018 Feb; 200(4):1360-1369. PubMed ID: 29335258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice.
    Deng T; Suo C; Chang J; Yang R; Li J; Cai T; Qiu J
    Cell Mol Immunol; 2020 Feb; 17(2):163-177. PubMed ID: 30760919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A primed dendritic cells activation exacerbated chronic murine colitis.
    Han F; Song J; Jia W; Yang M; Wang D; Zhang H; Shih DQ; Targan SR; Zhang X
    Life Sci; 2020 Dec; 262():118220. PubMed ID: 32781075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.
    Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A
    Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice.
    Li H; Song J; Niu G; Zhang H; Guo J; Shih DQ; Targan SR; Zhang X
    Pathol Res Pract; 2018 Feb; 214(2):217-227. PubMed ID: 29254800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells.
    Sun H; Shu J; Tang J; Li Y; Qiu J; Ding Z; Xuan B; Chen M; Gan C; Lin J; Qiu J; Sheng H; Wang C
    Immunology; 2024 Jul; 172(3):451-468. PubMed ID: 38544428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion.
    Wang D; Li H; Duan YY; Han F; Luo YX; Wu MY; Yang MY; Zhan RR; Song J; Zhang H; Zhang XL
    Life Sci; 2019 Aug; 231():116536. PubMed ID: 31176785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome.
    Jacob N; Jacobs JP; Kumagai K; Ha CWY; Kanazawa Y; Lagishetty V; Altmayer K; Hamill AM; Von Arx A; Sartor RB; Devkota S; Braun J; Michelsen KS; Targan SR; Shih DQ
    Mucosal Immunol; 2018 Sep; 11(5):1466-1476. PubMed ID: 29988118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 6 inhibits group 3 innate lymphoid cell function and gut immunity by suppressing IL-22 production.
    Su X; Zhao L; Zhang H; Wang D; Sun J; Shen L
    Front Immunol; 2024; 15():1402834. PubMed ID: 39253083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.
    Barrett R; Zhang X; Koon HW; Vu M; Chang JY; Yeager N; Nguyen MA; Michelsen KS; Berel D; Pothoulakis C; Targan SR; Shih DQ
    Am J Pathol; 2012 Feb; 180(2):636-49. PubMed ID: 22138299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis.
    Wenxiu J; Mingyue Y; Fei H; Yuxin L; Mengyao W; Chenyang L; Jia S; Hong Z; Shih DQ; Targan SR; Xiaolan Z
    Mediators Inflamm; 2021; 2021():5927064. PubMed ID: 34257516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.